MTK458

CAS No. 2499962-58-0

MTK458( —— )

Catalog No. M36457 CAS No. 2499962-58-0

MTK458 (EP-0035985) is an orally active and brain-permeable PINK1 activator that promotes pathological clearance of alpha-synuclein and reduces pUb in a PFF inoculation model.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
5MG 69 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MTK458
  • Note
    Research use only, not for human use.
  • Brief Description
    MTK458 (EP-0035985) is an orally active and brain-permeable PINK1 activator that promotes pathological clearance of alpha-synuclein and reduces pUb in a PFF inoculation model.
  • Description
    MTK458 is an orally active brain penetrant PINK1 activator. MTK458 binds to PINK1 and stabilizes an active heterocomplex, thereby increasing mitophagy. MTK458 can be used for research on Parkinson's disease.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Stratum of mice injected with α-synuclein preformed fibrils (PFFs) Dosage:50 mg/kg Administration:Oral gavage (p.o.), daily, 6 months Result:Rescued an activity deficit in freely moving PFF mice.Reduced the levels of inflammatory markers (TREM2, IL-6, and CXCL1).Animal Model:C57BL6J wildtype mice injected with PFF Dosage:50 mg/kg Administration:Oral gavage (p.o.); 7 days, 3 weeks Result:Decreased pUb in the brain and plasma of PFF seeded mice.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    PTEN
  • Recptor
    PTEN
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2499962-58-0
  • Formula Weight
    332.32
  • Molecular Formula
    C17H15F3N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (300.91 mM; Ultrasonic )
  • SMILES
    N(C1=C2C(NC(C(F)(F)F)=C2)=NC=N1)[C@H]3C=4C(CCC3)=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chin RM, et al. Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models. bioRxiv [Preprint]. 2023 Feb 15:2023.02.14.528378. ?
molnova catalog
related products
  • VO-Ohpic trihydrate

    VO-Ohpic trihydrate (VO-Ohpic) is a potent, selective and reversible PTEN inhibitor with IC50 of 35 nM in vitro.

  • bpV (HOpic)

    bpV (HOpic) is a potent inhibitor of PTEN (IC50 of 14 nM).?

  • MTK458

    MTK458 (EP-0035985) is an orally active and brain-permeable PINK1 activator that promotes pathological clearance of alpha-synuclein and reduces pUb in a PFF inoculation model.